For the first time, Health Canada has approved a new drug that targets the underlying cause of early-onset Alzheimer's disease. As health reporter Katherine Ward explains, doctors say this marks a ...

One of the most frightening things about Alzheimer's disease is how difficult it is to diagnose early. Now, University of ...

A gentle flicker of light and a steady hum of sound might help slow the course of Alzheimer’s disease. That’s the idea behind ...

An Australian man who was diagnosed with Alzheimer's at the age of 41 has now been told he doesn't have the disease ...

How well our memory works is determined by a complex combination of things, but we can assess it at home for free ...

A new research paper documents the outcomes of five volunteers who continued to receive 40Hz light and sound stimulation for ...

A leading dementia expert has revealed ten questions to ask yourself if you believe you may have Alzheimer's disease.

The annual “Walk to End Alzheimer’s” was one of five scheduled to be held across Mississippi this year. Hub City walkers ...

Labcorp, one of the country’s largest providers of diagnostic medical testing services, announced today that it will offer ...

The headset that began in a hospital lab now sits in the middle of marketing’s biggest debate: how much truth is too much.

Labcorp plans to make Roche's Elecsys® pTau181 test available nationwide by early 2026 BURLINGTON, N.C., Oct. 23, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global ...

The Burlington, N.C., lab-services company on Thursday said the Elecsys pTau181 test, developed by Swiss drugmaker Roche Holding and approved for commercialization by the U.S. Food and Drug ...